Recruiting
K-ras gene mutation+1
RecruitingEvaluation of Safety, Pharmacokinetics, and Efficacy of RO7782493 and Panitumumab in Advanced Solid Tumors with KRAS G12D Mutation
Registered drugNo placebo
Evaluation of Safety, Pharmacokinetics, and Efficacy of RO7782493 and Panitumumab in Advanced Solid Tumors with KRAS G12D Mutation
Registered drugNo placebo
- Disease:K-ras gene mutationNeoplasm
- Substances:PanitumumabRO7782493
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Panitumumab



